- Home
- APLT vs INO Comparison
APLT vs INO Comparison
Compare APLT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- INO
- Stock Information
- Founded
- APLT 2016
- INO 1979
- Country
- APLT United States
- INO United States
- Employees
- APLT N/A
- INO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- APLT Health Care
- INO Health Care
- Exchange
- APLT Nasdaq
- INO Nasdaq
- Market Cap
- APLT 63.6M
- INO 69.3M
- IPO Year
- APLT 2019
- INO 1998
- Fundamental
- Price
- APLT $0.41
- INO $2.18
- Analyst Decision
- APLT Buy
- INO Buy
- Analyst Count
- APLT 6
- INO 5
- Target Price
- APLT $6.10
- INO $8.80
- AVG Volume (30 Days)
- APLT 771.9K
- INO 2.1M
- Earning Date
- APLT 11-06-2025
- INO 11-13-2025
- Dividend Yield
- APLT N/A
- INO N/A
- EPS Growth
- APLT N/A
- INO N/A
- EPS
- APLT N/A
- INO N/A
- Revenue
- APLT $121,000.00
- INO $182,337.00
- Revenue This Year
- APLT N/A
- INO N/A
- Revenue Next Year
- APLT $5,931.24
- INO $15,960.33
- P/E Ratio
- APLT N/A
- INO N/A
- Revenue Growth
- APLT N/A
- INO N/A
- 52 Week Low
- APLT $0.30
- INO $1.30
- 52 Week High
- APLT $10.62
- INO $7.00
- Technical
- Relative Strength Index (RSI)
- APLT 38.50
- INO 47.09
- Support Level
- APLT $0.40
- INO $2.33
- Resistance Level
- APLT $0.46
- INO $2.98
- Average True Range (ATR)
- APLT 0.03
- INO 0.20
- MACD
- APLT -0.01
- INO -0.07
- Stochastic Oscillator
- APLT 7.74
- INO 2.44
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.